Galore777, I feel your pain. Still, I expected only 1cps, because DNA swallowed a whale this time last year and has a huge debt to pay down. So best that they direct FCF to pay down debt. In fact, the DNA report is upfront on its dividend vis business strategy -- DNA is in a growth phase and the lower dividend reflects that. Even so, expect 1cps minimum every 6 months, which is about 4% (although unfranked due to foreign income)at current sp.
I do believe that DNA's board should consider a share buyback if finances allow and if the sp remains low. A buyback won't necessarily raise the sp (it might provide a floor to some extent), but it would be prudent use of FCF due to undervaluation of DNA in the market.
